AGL 38.03 Decreased By ▼ -0.80 (-2.06%)
AIRLINK 139.50 Decreased By ▼ -3.90 (-2.72%)
BOP 5.59 Increased By ▲ 0.35 (6.68%)
CNERGY 3.89 Increased By ▲ 0.17 (4.57%)
DCL 7.62 Increased By ▲ 0.04 (0.53%)
DFML 45.66 Decreased By ▼ -0.74 (-1.59%)
DGKC 80.30 Decreased By ▼ -0.58 (-0.72%)
FCCL 27.70 Increased By ▲ 0.28 (1.02%)
FFBL 54.85 Decreased By ▼ -0.15 (-0.27%)
FFL 8.63 Increased By ▲ 0.07 (0.82%)
HUBC 115.90 Increased By ▲ 4.88 (4.4%)
HUMNL 11.40 Decreased By ▼ -0.02 (-0.18%)
KEL 3.97 Increased By ▲ 0.20 (5.31%)
KOSM 8.65 Increased By ▲ 0.32 (3.84%)
MLCF 35.20 No Change ▼ 0.00 (0%)
NBP 64.00 Increased By ▲ 2.65 (4.32%)
OGDC 170.00 Decreased By ▼ -1.90 (-1.11%)
PAEL 25.45 Decreased By ▼ -0.33 (-1.28%)
PIBTL 5.98 Increased By ▲ 0.01 (0.17%)
PPL 127.50 Decreased By ▼ -0.05 (-0.04%)
PRL 24.60 Decreased By ▼ -0.98 (-3.83%)
PTC 12.80 Increased By ▲ 0.65 (5.35%)
SEARL 57.74 Increased By ▲ 0.74 (1.3%)
TELE 7.14 Increased By ▲ 0.04 (0.56%)
TOMCL 34.93 Increased By ▲ 0.13 (0.37%)
TPLP 7.50 Increased By ▲ 0.55 (7.91%)
TREET 14.45 Increased By ▲ 0.60 (4.33%)
TRG 46.75 Decreased By ▼ -0.30 (-0.64%)
UNITY 26.15 Increased By ▲ 0.10 (0.38%)
WTL 1.21 No Change ▼ 0.00 (0%)
BR100 9,144 Increased By 51 (0.56%)
BR30 27,597 Increased By 279.3 (1.02%)
KSE100 86,035 Increased By 371.4 (0.43%)
KSE30 27,358 Decreased By -83.4 (-0.3%)

China''s state-owned chemical corporation ChemChina has asked US anti-trust regulators to greenlight its $43 billion acquisition of Swiss seed giant Syngenta, a report said Friday. China National Chemical Corp (ChemChina) has filed for approval from the Federal Trade Commission and the process is on track, Bloomberg News reported.
Winning the approval is a critical step towards wrapping up the biggest overseas take-over ever for a Chinese firm. US regulators have been a stumbling block for other Chinese deals. In December, American President Barack Obama blocked a Chinese company''s purchase of German semiconductor equipment maker Aixtron over security concerns, resulting in the termination of the deal a few days later.

Comments

Comments are closed.